Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Avricore Health Inc V.AVCR

Alternate Symbol(s):  AVCRF

Avricore Health Inc. is a pharmacy service company that is focused on acquiring and developing early-stage technologies. The Company is engaged in the business of health data and point-of-care technologies (POCT). It provides digital solutions that support the role of pharmacists and provide infrastructure for making clinical services more accessible and more affordable in its communities. The Company's offering includes HealthTab. HealthTab is a cloud-based network technology that enables the real-time response system where consumers receive a finger-stick blood test at their local pharmacy via a Web-enabled blood chemistry analyzer. Its HealthTab platform can test up to 27 biomarkers on the spot for screening and managing chronic conditions, such as diabetes. It also provides bacterial and viral testing for Strep and COVID-19. The Company's wholly owned subsidiary is HealthTab Inc.


TSXV:AVCR - Post by User

Bullboard Posts
Post by pennyDoctoron Dec 16, 2015 2:22pm
230 Views
Post# 24389160

Dec 18th last year

Dec 18th last yearIt was December last year when they granted options.  The current market price does have a lot to do with the setting of the option price and the approval by the TSX V for approval of the options.  The higher the market price the higher the opions have to be set for the directors.  I would like to see the price set at 3 times what the price was last year.  They still get a good deal out of that.  It was $.16 for 5 years and this year should be .48 for 5 more years.  Not a Penny less.   Realize by selling now you are helping with setting the option price lower than it needs to be and you are giving Arun a Christmas Present.
GLTA
Bullboard Posts

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse